Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 May;35(5):995–997. doi: 10.1128/aac.35.5.995

In vitro susceptibilities of clinical isolates of cysteine-requiring Escherichia coli to 12 antimicrobial agents.

C J McIver 1, J W Tapsall 1
PMCID: PMC245144  PMID: 1854183

Abstract

The MICs of 12 antimicrobial agents for 42 cysteine-requiring strains of Escherichia coli showed a high concordance when determined on three different media, one of which was supplemented with cysteine. Differences in the MICs of several agents were detected between 18 prototrophic revertants and their parent auxotrophs. A total of 64.7% of the isolates were fully susceptible to all agents, and no particular resistance pattern was evident.

Full text

PDF
995

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borderon E., Horodniceanu T. Metabolically deficient dwarf-colony mutants of Escherichia coli: deficiency and resistance to antibiotics of strains isolated from urine culture. J Clin Microbiol. 1978 Dec;8(6):629–634. doi: 10.1128/jcm.8.6.629-634.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brigham M. P., Stein W. H., Moore S. THE CONCENTRATIONS OF CYSTEINE AND CYSTINE IN HUMAN BLOOD PLASMA. J Clin Invest. 1960 Nov;39(11):1633–1638. doi: 10.1172/JCI104186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cohn D. L., Reimer L. G., Reller L. B. Comparative in-vitro activity of MK0787 (N-formimidoyl thienamycin) against 540 blood culture isolates. J Antimicrob Chemother. 1982 Mar;9(3):183–194. doi: 10.1093/jac/9.3.183. [DOI] [PubMed] [Google Scholar]
  4. DAVIS B. D., MINGIOLI E. S. Mutants of Escherichia coli requiring methionine or vitamin B12. J Bacteriol. 1950 Jul;60(1):17–28. doi: 10.1128/jb.60.1.17-28.1950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GILLESPIE W. A. Biochemical mutants of coliform bacilli in infections of the urinary tract. J Pathol Bacteriol. 1952 Jul;64(3):551–557. doi: 10.1002/path.1700640316. [DOI] [PubMed] [Google Scholar]
  6. HANCOCK R. Uptake of 14C-streptomycin by some microorganisms and its relation to their streptomycin sensitivity. J Gen Microbiol. 1962 Jul;28:493–501. doi: 10.1099/00221287-28-3-493. [DOI] [PubMed] [Google Scholar]
  7. McIver C. J., Tapsall J. W. Assessment of conventional and commercial methods for identification of clinical isolates of cysteine-requiring strains of Escherichia coli and Klebsiella species. J Clin Microbiol. 1990 Sep;28(9):1947–1951. doi: 10.1128/jcm.28.9.1947-1951.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. McIver C. J., Tapsall J. W. Cysteine requirements of naturally occurring cysteine auxotrophs of Escherichia coli. Pathology. 1987 Oct;19(4):361–363. doi: 10.3109/00313028709103884. [DOI] [PubMed] [Google Scholar]
  9. Murray P. R., Niles A. C. Inactivation of penicillins by Thiol broth. J Clin Microbiol. 1982 Nov;16(5):982–984. doi: 10.1128/jcm.16.5.982-984.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Tapsall J. W., McIver C. J. Septicaemia caused by cysteine-requiring isolates of Escherichia coli. J Med Microbiol. 1986 Dec;22(4):379–382. doi: 10.1099/00222615-22-4-379. [DOI] [PubMed] [Google Scholar]
  11. Wilcken D. E., Gupta V. J. Sulphr containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide. Eur J Clin Invest. 1979 Aug;9(4):301–307. doi: 10.1111/j.1365-2362.1979.tb00888.x. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES